Compare KZR & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZR | TVGN |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 63.9M |
| IPO Year | 2018 | N/A |
| Metric | KZR | TVGN |
|---|---|---|
| Price | $7.36 | $5.98 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 88.4K | 29.5K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $0.14 |
| 52 Week High | $7.55 | $10.76 |
| Indicator | KZR | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 62.35 | 63.99 |
| Support Level | $6.06 | $0.47 |
| Resistance Level | N/A | $10.76 |
| Average True Range (ATR) | 0.18 | 0.51 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 89.12 | 80.84 |
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.